Apoptosis-inducing proteins with reduced expression in breast cancer: A review article

Breast cancer is considered one of the most abundant malignancies with high morbidity and mortality. Traditional cancer treatments possess various weaknesses, including a lack of specificity and numerous side effects. Novel cancer therapies aim to overcome the shortcomings of traditional therapies a...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Mehdi Khaleghi, Faezeh Rouhi, Kourosh Eslami, Fatemeh Shafiee
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580825000184
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206849423540224
author Mohammad Mehdi Khaleghi
Faezeh Rouhi
Kourosh Eslami
Fatemeh Shafiee
author_facet Mohammad Mehdi Khaleghi
Faezeh Rouhi
Kourosh Eslami
Fatemeh Shafiee
author_sort Mohammad Mehdi Khaleghi
collection DOAJ
description Breast cancer is considered one of the most abundant malignancies with high morbidity and mortality. Traditional cancer treatments possess various weaknesses, including a lack of specificity and numerous side effects. Novel cancer therapies aim to overcome the shortcomings of traditional therapies and offer more efficient and safe treatments. Designing and identifying novel proteins that can practically and specifically inhibit tumors by inducing apoptosis can interest researchers in this field. This review discusses recent studies on the use of four promising proteins, KAI1, Apoptin, BIF-1, and DFF-40, for breast cancer treatment. This study also focuses on alterations in the expression of the androgenic proteins and novel strategies for better penetration and delivery of these proteins. Lastly, prospects for protein-based targeted cancer therapy and future studies in this field are highlighted.
format Article
id doaj-art-1f59040ce74d4469a2fd77da9b49bb83
institution Kabale University
issn 2405-5808
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Biochemistry and Biophysics Reports
spelling doaj-art-1f59040ce74d4469a2fd77da9b49bb832025-02-07T04:47:51ZengElsevierBiochemistry and Biophysics Reports2405-58082025-03-0141101931Apoptosis-inducing proteins with reduced expression in breast cancer: A review articleMohammad Mehdi Khaleghi0Faezeh Rouhi1Kourosh Eslami2Fatemeh Shafiee3Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranBioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran; Bioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran; Corresponding author. School of Pharmacy and Pharmaceutical Sciences. Isfahan University of Medical Sciences, Hezar Jarib Ave. Isfahan, Iran.Breast cancer is considered one of the most abundant malignancies with high morbidity and mortality. Traditional cancer treatments possess various weaknesses, including a lack of specificity and numerous side effects. Novel cancer therapies aim to overcome the shortcomings of traditional therapies and offer more efficient and safe treatments. Designing and identifying novel proteins that can practically and specifically inhibit tumors by inducing apoptosis can interest researchers in this field. This review discusses recent studies on the use of four promising proteins, KAI1, Apoptin, BIF-1, and DFF-40, for breast cancer treatment. This study also focuses on alterations in the expression of the androgenic proteins and novel strategies for better penetration and delivery of these proteins. Lastly, prospects for protein-based targeted cancer therapy and future studies in this field are highlighted.http://www.sciencedirect.com/science/article/pii/S2405580825000184ApoptosisBreast neoplasmsDown-regulationGene expressionProteins
spellingShingle Mohammad Mehdi Khaleghi
Faezeh Rouhi
Kourosh Eslami
Fatemeh Shafiee
Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
Biochemistry and Biophysics Reports
Apoptosis
Breast neoplasms
Down-regulation
Gene expression
Proteins
title Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
title_full Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
title_fullStr Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
title_full_unstemmed Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
title_short Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
title_sort apoptosis inducing proteins with reduced expression in breast cancer a review article
topic Apoptosis
Breast neoplasms
Down-regulation
Gene expression
Proteins
url http://www.sciencedirect.com/science/article/pii/S2405580825000184
work_keys_str_mv AT mohammadmehdikhaleghi apoptosisinducingproteinswithreducedexpressioninbreastcancerareviewarticle
AT faezehrouhi apoptosisinducingproteinswithreducedexpressioninbreastcancerareviewarticle
AT kourosheslami apoptosisinducingproteinswithreducedexpressioninbreastcancerareviewarticle
AT fatemehshafiee apoptosisinducingproteinswithreducedexpressioninbreastcancerareviewarticle